New drug for Alzheimer's disease wins FDA advisory committee's approval
June 17, 2024
June 17, 2024
ANN ARBOR, Michigan, June 17 -- The University of Michigan issued the following news:
EXPERTS ADVISORY
An FDA advisory committee recommended this week that the Food and Drug Administration make donanemab, an anti-amyloid treatment available as a treatment option for the estimated 6.7 million people in the United States who live with Alzheimer's disease.
The new therapy, given intravenously, appears to slow cognitive decline by attaching and removing a prote . . .
EXPERTS ADVISORY
An FDA advisory committee recommended this week that the Food and Drug Administration make donanemab, an anti-amyloid treatment available as a treatment option for the estimated 6.7 million people in the United States who live with Alzheimer's disease.
The new therapy, given intravenously, appears to slow cognitive decline by attaching and removing a prote . . .